Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | A445A | Silent | 1 |
| BLCA | Bladder urothelial carcinoma | D393D | Silent | 1 |
| BLCA | Bladder urothelial carcinoma | E211Q | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E235K | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E237Q | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E396K | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | W412C | Missense | 1 |
| CESC | Cervical and endocervical cancers | L202L | Silent | 1 |
| COAD | Colon adenocarcinoma | E301E | Silent | 1 |
| GBM | Glioblastoma multiforme | M296T | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | H155H | Silent | 1 |
| HNSC | Head and Neck squamous cell carcinoma | N306S | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | R395S | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | T370I | Missense | 1 |
| KIRC | Kidney renal clear cell carcinoma | S240C | Missense | 1 |
| KIRP | Kidney renal papillary cell carcinoma | G286V | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | D340Y | Missense | 1 |
| LUAD | Lung adenocarcinoma | A115V | Missense | 1 |
| LUAD | Lung adenocarcinoma | A454A | Silent | 1 |
| LUAD | Lung adenocarcinoma | E233Q | Missense | 1 |
| LUAD | Lung adenocarcinoma | M157I | Missense | 1 |
| OV | Ovarian serous cystadenocarcinoma | G352E | Missense | 1 |
| PAAD | Pancreatic adenocarcinoma | R208R | Silent | 1 |
| PRAD | Prostate adenocarcinoma | Q287K | Missense | 1 |
| READ | Rectum adenocarcinoma | A321A | Silent | 1 |
| STAD | Stomach adenocarcinoma | A128V | Missense | 1 |
| STAD | Stomach adenocarcinoma | Q100* | Nonsense | 1 |
| STAD | Stomach adenocarcinoma | Q273R | Missense | 1 |
| STAD | Stomach adenocarcinoma | R208H | Missense | 1 |
| TGCT | Testicular Germ Cell Tumors | V32G | Missense | 1 |
| THCA | Thyroid carcinoma | V40V | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | A353A | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | E237E | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | I191I | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R268W | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R338H | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | S399S | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | T426T | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | Y188C | Missense | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 14.3 | 20.8 | 0 |
| BRCA | Breast invasive carcinoma | 976 | 0 | 0 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 7.1 | 0 | 0 |
| COAD | Colon adenocarcinoma | 367 | 7.1 | 0 | 0 |
| ESCA | Esophageal carcinoma | 185 | 0 | 0 | 0 |
| GBM | Glioblastoma multiforme | 283 | 0 | 4.2 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 7.1 | 12.5 | 0 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 0 | 4.2 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 0 | 4.2 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | 0 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 0 | 4.2 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 7.1 | 12.5 | 0 |
| LUSC | Lung squamous cell carcinoma | 177 | 0 | 0 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 0 | 4.2 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 7.1 | 0 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 0 | 4.2 | 0 |
| READ | Rectum adenocarcinoma | 122 | 7.1 | 0 | 0 |
| SARC | Sarcoma | 247 | 0 | 0 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 0 | 0 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 0 | 12.5 | 100 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 4.2 | 0 |
| THCA | Thyroid carcinoma | 495 | 7.1 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 35.7 | 12.5 | 0 |